Background of Adoption and Purpose of Collaboration with Microsoft Corporation
MEDINET has been developing AI technology for estimating the severity of acute care patients and a critical care management system that provides this functionality. The Company will accelerate the development of the patient evaluation technology based on video image analysis, which is the core of iBSEN, by being selected for the "Microsoft for Startups" program. In addition, the company will promote the utilization of data throughout the acute care medical field by utilizing cloud technology, jointly promote and announce R&D achievements with Microsoft, and develop new services and partners through collaboration between companies using Azure and "iBSEN", The company also aims to discover partner companies and release services outside of Japan through access to its global network.
What is "Microsoft for Startups"?
The Microsoft Startup Support Program is a global startup support program offered by Microsoft Corporation and deployed in more than 140 countries around the world. The program aims to accelerate the growth of startups with unique and innovative technical solutions. The startups selected for the program will receive access to Microsoft's powerful technologies, including Azure, as well as dedicated resources for business expansion through the company's partner network.
About iBSEN, a critical care management system
iBSEN is a system for advanced patient monitoring and information sharing through AI-based image analysis and other means. By aggregating, analyzing, and visualizing all medical information scattered throughout the medical field, medical professionals can provide high-quality patient monitoring and evaluation anytime, anywhere, and from any device, without relying on experience or knowledge. By being able to quickly determine which patients are in a condition in which medical resources should be prioritized, the system can reduce the number of sudden changes and deaths that could have been prevented, and can also contribute to the efficient operation of critical care beds and the reduction of labor for healthcare professionals.
About CROSS SYNC Corporation
It is a "Yokohama City University venture" with the vision of "ICU Anywhere" established in October 2019 by Dr. Takagi, an intensivist who is the head of the Intensive Care Department at Yokohama City University Hospital, and his colleagues. The company's mission is to "use technology to assist expertise in the medical field," and it has developed and offers "iBSEN," a critical care management system with AI as its core technology, based on the idea of "eliminating preventable sudden patient changes and deaths. By promoting the utilization of medical information that overflows into the medical field and enabling information sharing in the medical field that does not depend on experience and expertise, the company is keenly working to solve social issues such as the establishment of a new medical system to cope with the spread of emerging infectious diseases and the collapse of the supply-demand balance of medical care due to the super aging of the population.
| name of company | CROSS SYNC Corporation |
| Establishment | October 2019 |
| Location | Head Office Address : Clinical Research Building A507, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, Japan Office Address: PS-006, NANA Lv. in Yokohama Landmark Tower, 7th floor, 2-2-1 Minato Mirai, Nishi-ku, Yokohama, Kanagawa, Japan |
| representative | Representative Directors : Shunsuke Takagi and Fumihiko Uemura |
| uniform resouce locator | https://cross-sync.co.jp/ |









